Who gains from saving nature
Ledger 1 : 33 — For each dollar financing nature-based solutions in 2023, about $33 financed activities harmful to nature. (UNEP)
Cases / Biotech, cloning and de-extinction · Canada · 1993–2013

Nexia Biotechnologies: BioSteel spider-silk goats and Protexia

Nature's voice · report
No measurement of the harm done to me here is on record.
Did nature suffer? Not measured.
Not on record
  • The record does not name which of my species, waters, soils or forests were harmed.
What the record lacks: 5 none on record · 1 not disclosed · 6 insufficient · 1 not measured · 1 disputed · 1 unclear See the gaps

A Canadian company announced goats that produced a spider-silk protein in their milk and promised bulletproof vests and surgical thread. Its sellable asset proved to be a nerve-agent antidote made the same way, and the company went bankrupt in 2009.

Several thousand vs about 50Herd announced as the goal vs herd reported
Nexia's stated goal (ABC News, January 2002) against the herd size reported for the same period. Counts as reported; not independently audited.

Status As of October 2026: Nexia went bankrupt in 2009; the sources reviewed record no commercial BioSteel product and no court case.

What?
A company engineered goats to produce a spider-silk protein in their milk, promised bulletproof vests and surgical thread, and sold its only marketable asset, a goat-milk nerve-agent antidote, in 2005 before going bankrupt in 2009. Wikipedia
Where?
Near Montreal, Canada (company); goats later held in Wyoming and Utah, United States, and two at the Canada Agriculture Museum in Ottawa.
When?
1993 to 2013: founded 1993, goats presented 2000, fibres announced 2002, assets sold 2005, bankruptcy 2009, contract not extended 2010.
Who?
Gained
  • Holders of Nexia shares on 18 January 2002 — The share price rose 39% on the announcement day.
  • PharmAthene — Acquired the Protexia assets and herd in 2005. Research Money
  • AFMNet — Bought Nexia's spider-silk assets in 2009 at an undisclosed price.
  • University of Wyoming — Received most of the herd in 2007.
Lost
  • PharmAthene — Closed its Canadian Protexia operations and recorded an impairment of about US$4.6 million after the Department of Defense did not extend the contract. PharmAthene / US SEC
  • Nexia — Went bankrupt in 2009.
Harmed
None on record
Why?
The sources reviewed state the company's stated aims: lightweight armour, surgical thread and fishing line. They do not state a conservation purpose. Hayadan
How?
Spider-web protein genes were inserted into goats so they were active only in the mammary gland; fibres were drawn from the protein purified from milk. Museum of PostNatural History (Swiss page)
6 of 6 questions answered from the record

What happened

The record, in order.

Nexia Biotechnologies was founded in 1993 by Jeffrey Turner and Paul Ballard, with roots at McGill University, according to Wikipedia's entry on BioSteel. The company licensed a patent from Randy Lewis of the University of Wyoming on spider-web protein genes and inserted those genes into goats so that they worked only in the mammary gland. The goats' milk contained the protein that spider silk is built from; fibres were then spun from the protein in the laboratory.

In May 2000 a Guardian report, reproduced in Hebrew by Hayadan on 22 May 2000, introduced two male goats, Webster and Peter. It quoted Turner as saying that one goat's milk over one month would be enough to make a vest, and wrote that the Pentagon wanted the material for missile defence and the US and Canadian armies for lightweight vests. In January 2002 Nexia and a US Army research unit based at Natick announced the first fibres drawn from protein made in mammalian cells. The Globe and Mail reported that Nexia's shares rose 39% on the day, to close at C$6.95 in Toronto.

ABC News reported in January 2002 that Turner expected sutures and biodegradable fishing line in 2003 or 2004, lightweight body armour three to five years after that, and a herd of "several thousand" goats. The Globe and Mail reported in the same month that the fibres were close to natural silk in elasticity and toughness but had only 20–30% of its tensile strength, and described the material in side panels as stronger than steel and Kevlar. According to ABC, fibre output was at the level of "a few strands".

Nexia's marketable asset was not spider silk but Protexia, a nerve-agent antidote (human butyrylcholinesterase) produced in goat milk. After failing to raise new financing, Nexia sold its Protexia assets and goat herd to PharmAthene in 2005; Research Money reported proceeds of $15.6 million and the resignation of founder Turner. In its annual report for 2010, PharmAthene said the US Department of Defense did not extend the Protexia contract beyond 31 December 2010. PharmAthene closed its Canadian Protexia operations and recorded an impairment of about US$4.6 million.

According to the Canadian Science and Technology Museums Corporation (Ingenium), Nexia did little more to develop BioSteel after 2005. Most of the herd went to the University of Wyoming in 2007, and in 2009 the federally funded research network AFMNet bought Nexia's spider-silk assets; the price was not disclosed. Nexia went bankrupt in 2009. Two goats, Sugar and Spice, were sold to the Canada Agriculture Museum in Ottawa, which removed them from display in 2013 after public pressure (AgFunderNews, 2019). Lewis's laboratory at Utah State University kept about 30 goats in 2012 and more than 20 in 2019.

  1. 1993Nexia Biotechnologies founded (Jeffrey Turner, Paul Ballard)
  2. 2000Company raises capital and lists; goats Webster and Peter presented to the press (22 May); one goat-month of milk said to be enough for a vest
  3. 2002First fibres announced with a US Army unit (January); shares up 39% on the day; sutures and fishing line promised for 2003–04
  4. 2005Protexia assets and goat herd sold to PharmAthene; founder Turner resigns
  5. 2006US Department of Defense Protexia contract reported at up to $213 million (unverified)
  6. 2007Most of the remaining spider-silk herd goes to the University of Wyoming
  7. 2009AFMNet buys Nexia's spider-silk assets; Nexia goes bankrupt
  8. 2010Defense Department does not extend the Protexia contract beyond 31 December; PharmAthene closes Canadian operations and records about US$4.6 million impairment
  9. 2013Two goats removed from display at the Canada Agriculture Museum after public pressure
  10. 2017Utah State University reports about 0.5 g of recovered protein per litre of goat milk

What was said

Claims, in the words of those who made them.

Where accounts differ

Each party's account, side by side, with its source. The record does not settle these points; it shows them.

Did the fibres meet what was promised?
Company or project
Nexia (Jeffrey Turner)

Expected sutures and fishing line in 2003 or 2004, body armour three to five years later, and a herd of several thousand goats.

Press and investigations
Globe and Mail

Fibres were close to natural silk in elasticity and toughness but had 20–30% of its tensile strength.

Press and investigations
ABC News

Fibre production was at the level of a few strands.

How it looked

What was shown, beside what was recorded.

Shown

  • One goat's milk over one month would be enough to make a vest.
    Jeffrey Turner, Nexia, as reported by the Guardian and reproduced by Hayadan (22 May 2000) · Hayadan
  • Sutures and biodegradable fishing line in 2003 or 2004; lightweight body armour three to five years later; a herd of several thousand goats.
    Jeffrey Turner, Nexia, as reported by ABC News (January 2002)
  • The material described as stronger than steel and Kevlar.
    Globe and Mail side panels (January 2002)

Recorded

  • Fibres reported at 20–30% of the tensile strength of natural silk (Globe and Mail, January 2002).
  • Fibre output at the level of "a few strands" (ABC News, January 2002).
  • Recovered protein of about 0.5 g per litre of goat milk at Utah State University in 2017; a 2022 systematic review in Frontiers described purification from goat milk as long, expensive and inefficient.
  • Nexia sold its Protexia assets and herd in 2005 and went bankrupt in 2009; the Defense Department did not extend the Protexia contract after 31 December 2010.
  • The sources reviewed record no sale of a commercial BioSteel product.

Who gained

Money that reached nature, beside money that stayed elsewhere.

Reached nature or the ground

Not published
No figure published.

Gained elsewhere

Not totalled
Currency: USD · Window: 1993–2010. All figures cover the same period. * Estimate built from cited figures.

Responses on record

  • nexia (January 2002): Jeffrey Turner said sutures and biodegradable fishing line would arrive in 2003 or 2004, body armour three to five years later, and that the herd would grow to several thousand goats.
  • pharmathene (FY2010 (10-K)): Its annual report for 2010 said the Department of Defense did not extend the Protexia contract beyond 31 December 2010, citing concerns about the duration of protection and budget; the company closed its Canadian Protexia operations and recorded an impairment of about US$4.6 million. · PharmAthene / US SEC

In court and with insurers

Every proceeding and every insurer decision on record.

Lawsuits and rulings

No court case on record. No court has ruled on this case.

Insurers

No insurer decision on record.

What nature saw

Outcomes measured on the ground, and nature's note.

Nature's report opens this page. Below: further outcomes measured on the ground.

Herd goal vs herd reported
Several thousand vs about 50
Goal stated in January 2002 (ABC News); herd of about 50 reported for the same period
Fibre strength
20–30%
Of natural spider silk, tensile strength (Globe and Mail, January 2002)
Goats at Utah State University
About 30 → 20+
2012 and 2019 counts; later status not on record

What we don't know

Undisclosed, unproven, untried: recorded as data.

Nature

  • Not measured Harm to nature: The record holds no measurement of harm to nature.

Figures

  • Insufficient Ipo proceeds: From a museum page; no primary document.
  • Insufficient Contract ceiling: Reported Department of Defense Protexia contract; secondary report only.

Accounts

  • Disputed Did the fibres meet what was promised?

Record

  • None on record The exact amount and currency of Nexia's 2000 share offering: a museum page gives $40 million, but no primary document is cited.
  • None on record How much money the US Army put into the project: sources say only "joint research".
  • Unclear Whether any BioSteel product (suture thread, fishing line) was ever sold commercially: no sale is on record, and the absence is not proven either.
  • None on record Capital raised 1993–2000 is given as $67 million with no currency stated (Edward Willett, reproducing the National Post).
  • None on record Herd size in 2002: one source gives about 50 goats, a museum page gives about 150 and a claim of up to 20 g of protein per litre; the museum's claim has no primary source.
  • Insufficient Reported but not independently verified: the sale of the Protexia assets was announced at US$18 million, closing at US$11.2 million in cash plus shares.
  • Insufficient Reported but not independently verified: in September 2006 the Department of Defense signed a Protexia contract worth "up to" US$213 million, of which US$34.7 million was firmly allocated to the first phase.
  • Insufficient Reported but not independently verified: grants to Lewis's laboratory from the Navy, Army, Department of Energy and National Science Foundation, about $1.15 million (2013), $1.9 million (2014), $1 million (2015) and $420,000 (2018).
  • Insufficient Reported but not independently verified: the Science citation for the January 2002 fibres (Lazaris et al., volume 295) rests on secondary summaries.
  • None on record The status of the Utah State goat herd after 2019.
  • Not disclosed The sale price AFMNet paid for Nexia's spider-silk assets: not disclosed.

Did the harm stop?

Not applicable on the record: the sources reviewed describe a commercial and research promise rather than an operation with documented damage to nature.

Who paid?

Investors who financed Nexia (capital of $67 million raised 1993–2000, currency not stated) and, after 2005, the PharmAthene operations that were closed in 2010 with an impairment of about US$4.6 million. The sources reviewed do not trace losses to any other party.

Sources

Voices on record: ✓ Company or project— Government and regulators— Courts✓ Press and investigations— Communities and civil society— Researchers

Company or project

Connected cases

Related matters, and cases linked to this one through the same organisations, with the role each played in both.

Bonds and banking

Liquidation, insolvency, bankruptcy
Legal processes that apply when a company cannot pay its debts; its assets are sold and claims against it may go unpaid.

Institutions

SEC
The US Securities and Exchange Commission, which regulates securities markets and what companies tell investors.

Science and environment

PFOA (C8) and PFAS
PFAS are a large family of human-made chemicals that persist in the environment and the body; PFOA, also called C8, is one of them and was used to make Teflon.